TABLE 1

Estimated Radiation-Absorbed Doses to Adult Human After Intravenous Injection of 89Zr-Df-Pembrolizumab in PBL and NSG Mice (n = 4)

PBL model (NSG mice with human PBMCs)NSG mice
OrganmGy/MBqSDrad/mCiSDmGy/MBqSDrad/mCiSD
Adrenals0.0280.0010.1040.0010.0280.0010.1050.001
Brain0.2490.0050.9190.0190.2450.0060.9050.022
Breasts0.1850.0010.6830.0050.1850.0020.6840.008
Small intestine0.0250.0010.0910.0010.0250.0010.0910.001
Stomach wall0.6300.0042.3290.0140.6300.0052.3320.019
Kidneys0.0300.0010.1130.0050.0350.0010.1280.005
Liver1.2070.0224.4650.0831.1960.0614.4260.225
Lungs0.5560.0042.0590.0160.5620.0032.0780.010
Muscle0.0190.0010.0700.0020.0190.0010.0720.001
Ovaries1.5910.0065.8850.0231.5940.0135.8970.046
Pancreas0.0290.0010.1080.0010.0290.0010.1080.002
Red marrow0.5330.0031.9700.0100.5330.0041.9720.014
Skin0.3730.0021.3800.0080.3730.0031.3780.012
Spleen0.0300.0010.1120.0020.0280.0070.1040.027
Thymus0.0240.0010.0870.1010.0240.0130.0890.048
Salivary glands1.2460.0824.6090.0130.8380.0043.0990.014
Urinary bladder wall0.5730.0042.1180.0010.5740.0012.1250.002
Uterus0.0260.0010.0970.0010.0260.0010.0970.001
Total-body effective dose (mSv/MBq)0.5970.0050.5810.003